Generalized CNS disease and massive G(M1)-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase

Human Molecular Genetics

Volumn 6, Issue 2, 1997, Pages 205-211

  Hahn, Christopher N ^a   Del Pilar Martin, Maria ^a   Schröder, Maria ^b   Vanier, Marie T ^c   Hara, Yoji ^b   Suzuki, Kinuko ^b   Suzuki, Kunihiko ^b   D'Azzo, Alessandra ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GANGLIOSIDE GM1; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; ENZYME DEFICIENCY; GAIT DISORDER; GM1 GANGLIOSIDOSIS; LIPID STORAGE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SPINAL CORD NERVE CELL; TREMOR;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; G(M1) GANGLIOSIDE; GANGLIOSIDES; GANGLIOSIDOSIS, GM1; GLYCOSPHINGOLIPIDS; HUMANS; MICE; MICE, INBRED C57BL;

ANIMALIA; ATAXIA;

EID: 0031046840     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.2.205     Document Type: Article

References (38)

1. Suzuki, Y., Sakuraba, H. and Oshima, A. (1995) In Scriver, C., Beaudet, A., Sly, W. and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Publishing Co., New York, Vol. 2, pp. 2785-2824.
2. Gravel, R.A., Clarke, J.T.R., Kaback, M.M., Mahuran, D., Sandhoff, K. and Suzuki, K. (1995) In Scriver, C., Beaudet, A., Sly, W. and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Publishing Co., New York, Vol. 2, pp. 2839-2879.
3. Schuchman, E.H. and Desnick, R.J. (1995) In Scriver, C., Beaudet, A., Sly, W. and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Publishing Co., New York, Vol. 2, pp. 2601-2624.
4. Suzuki, K. (1991) A review: neuropathology of late onset gangliosidosis. Dev. Neurosci, 13, 205-210.
5. M1-gangliosidosis). J. Lipid Res., 8, 105-113.
6. M1-gangliosdosis (generalized gangliosidosis). J. Neuropathol. Exp. Neurol., 28, 25-73.
7. M1-gangliosidosis: chemical pathology of visceral organs. Science, 159, 1471-1472.
8. Oshima, A., Tsuji, A., Nagao, Y., Sakuraba, H. and Suzuki, Y. (1988) Cloning, sequencing, and expression of cDNA for human beta-galactosidase. Biochem. Biophys. Res. Commun., 157, 238-244.
9. Morreau, H., Galjart, N.J., Gillemans, N., Willemsen, R., van der Horst, G.T.J. and d'Azzo, A. (1989) Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J. Biol. Chem., 264, 20655-20663.
10. Yamamoto, Y., Hake, C.A., Martin, B.M., Kretz, K.A., Ahem-Rindell, A.J., Naylor, S.L., Mudd, M. and O'Brien, J.S. (1990) Isolation, characterization, and mapping of a human acid beta-galactosidase cDNA. DNA Cell. Biol., 9, 119-127.
11. Morreau, H., Bonten, E., Zhou, X.Y. and d'Azzo, A. (1991) Organization of the gene encoding human lysosomal β-galactosidase. DNA Cell. Biol., 10, 495-504.
12. M1-gangliosidosis: a common mutation among Japanese adult; chronic cases. Am. J .Hum. Genet., 49, 435-442.
13. M1-gangliosidosis (genetic β-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients. Am. J. Hum. Genet., 49, 566-574.
14. Oshima, A., Yoshida, K., Shimmoto, M., Fukuhara, Y, Sakuraba, H. and Suzuki, Y. (1991) Human β-galactosidase gene mutations in Morquio B disease. Am. J. Hum. Genet., 49, 1091-1093.
15. M1-gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients. Ann. Neurol., 31, 328-332.
16. M1-gangliosidosis patient. Hum. Genet., 90, 247-250.
17. M1-gangliosidosis. Hum. Genet., 91, 407.
18. M1-gangliosidosis in American patients. Am. J. Hum. Genet., 53, 881-888.
19. M1-gangliosidosis. Am. J. Hum. Genet., 54, 1004-1013.
20. Ishii, N., Oohira, T., Oshima, A., Sakuraba, H., Endo, F., Matsuda, I., Sukagawa, K., Orii, T. and Suzuki, Y. (1996) Clinical and molecular analysis of a Japanese boy with Morquio B disease. Clin. Genet., 48, 103-108.
21. M1-gangliosidosis. Hum. Mutat., 3, 112-120.
22. M1-gangliosidosis. Glycoconjugate J., 12, 461A.
23. Tanaka, H. and Suzuki, K. (1977) Substrate specificities of the two genetically distinct human brain β-galactosidases. Brain Res., 122, 325-335.
24. Chen, Y.Q. and Wenger, D.A. (1993) Galactocerebrosidase from human urine: purification and partial characterization. Biochim. Biophys. Acta, 1170, 53-61.
25. Yamanaka, S., Johnson, M.D., Grinberg, A., Westphal, H., Crawley, J.N., Taniike, M., Suzuki, K. and Proia, R.L. (1994) Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl Acad. Sci. USA, 91, 9975-9979.
26. Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M.P., Crawley, J.N., Sandhoff, K., Suzuki, K. and Proia, R.L. (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nature Genet., 11, 170-176.
27. M2 gangliosidosis subjects. Ear. J. Biochem., 149, 247-255.
28. M2 in Neuro2a cells by sialidase. J. Neurochem., 64, 451-454.
29. Nanba, E. and Suzuki, K. (1990) Molecular cloning of mouse acid β-galactosidase cDNA: sequence, expression of catalytic activity and comparison with the human enzyme. Biochem. Biophys. Res. Commun., 173, 141-148.
30. Mansour, S.L., Thomas, K.R. and Capecchi, M.R. (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to nonselectable genes. Nature, 336, 348-352.
31. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. and Mulligan, R.C. (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell, 65, 1153-1163.
32. van Deursen, J., Heerschap, A., Oerlemans, F., Ruitenbeek, W., Jap, P., ter Laak, H. and Wieringa, B. (1993) Skeletal muscles of mice deficient in M-CK lack burst activity. Cell, 74, 621-631.
33. Zhou, X.Y, Morreau, H., Rottier, R., Davis, D., Bonten, E., Gillemans, N., Wenger, D., Grosveld, F.G., Doherty, P., Suzuki, K., Grosveld, G.C. and d'Azzo, A. (1995) Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with over-expressing erythroid precursor cells. Genes Dev., 9, 2623-2634.
34. Galjaard, H. (1980) Genetic Metabolic Disease: Diagnosis and Prenatal Analysis. Elsevier Science Publishers B.V., Amsterdam.
35. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. and Klenk, D.C. (1985) Measurement of protein using bicinchoninic acid [published erratum appears in Anal. Biochem., 163, 279, 1987]. Anal. Biochem., 150, 76-85.
36. Svennerholm, L., Hakansson, G., Mansson, J.-E. and Vanier, M.T. (1979) The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin. Chim. Acta, 92, 53-64.
37. Fujita, N., Suzuki, K., Vanier, M.T., Popko, B., Maeda, N., Klein, A., Henseler, M., Sandhoff, K., Nakayasu, H. and Suzuki, K. (1996) Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet., 5, 711-725.
38. Holmes, E.W. and O'Brien, J.S. (1979) Separation of glycoprotein derived oligosaccharides by thin-layer chromatography. Anal. Biochem., 93, 167-170.